S

Shoreline Biosciences, Inc.

84 employees

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Life Science

Date founded

2020

Funding rounds raised

Total raised

$140M

from 15 investors over 15 rounds

S

Shoreline Biosciences, Inc. raised $140M on November 2, 2021

Investors: NS Investment, Kingdon Capital Management, Wedbush Securities, Irving Investors, Stork Capital S.à.r.l., -, -, Eventide Asset Management and Piper Sandler

S

Shoreline Biosciences, Inc. raised $43M on February 7, 2021

Investors: -, Stork Capital S.à.r.l., Commodore Capital, LP, Gilead Capital LP, Logos Global Management, LP and Cormorant Capital

FAQ